中国放射性同位素进展(2016—2025年)

Domestic Developments in Isotope Technology (2016−2025)

  • 摘要: 近十年(2016—2025年)是中国同位素技术实现从依赖进口到自主创新的战略转型期。为系统分析该领域的突破性进展与现存挑战,本文基于近十年同位素技术领域的国家政策规划、生产设施建设、关键技术研发、放射源应用、放射性药物获批、产业园布局、研发平台建设等七个方面,综合政策文本、技术报告与产业数据进行梳理、归纳,对存在的问题和不足进行分析,并针对问题提出后续发展建议。

     

    Abstract: The past decade (2016–2025) marks a strategic transition period for China’s isotope technology to transform from reliance on imports to independent innovation. To systematically analyze the breakthroughs and existing challenges in this field, this paper examines seven key areas over the past decade: national policy planning, production facility construction, research and development of core technologies, market entry of isotope products, radioactive source applications, radiopharmaceuticals, industrial park layout, and R&D platform construction. It integrates policy documents, technical reports, and industrial data, conducts a comprehensive review and summary, and analyzes existing issues and shortcomings. Suggestions for subsequent development have been proposed in response to the identified issue.

     

/

返回文章
返回